Compugen (CGEN) EBIT (2009 - 2026)
Compugen (CGEN) reported EBIT of $9.0 million for Q1 2026, up 7.41% on a YoY basis from $8.4 million in Q1 2025, and down 83.91% sequentially from $56.0 million in Q4 2025.
Compugen (CGEN) EBIT (2009 - 2026) Analysis & Trends
Compugen (CGEN) has 18 years of EBIT data on file, last reported at $9.0 million in Q1 2026.
- For the quarter ending Q1 2026, EBIT rose 7.41% year-over-year to $9.0 million; the trailing twelve-month figure through Mar 2026 stood at $31.9 million (up 313.16% YoY), and the FY2025 full-year result was $31.3 million, up 310.37% from the prior year.
- EBIT fell to $9.0 million in Q1 2026, from $56.0 million in the prior quarter.
- In the past five years, EBIT ranged from a high of $56.0 million in Q4 2025 to a low of -$30.5 million in Q2 2023.
- A 5-year average of $916058.8 and a median of -$3.5 million in 2022 frame the typical range for EBIT.
- Peak annual rise in EBIT reached 848.94% in 2025, while the deepest fall reached 275.56% in 2025.
- Tracing CGEN's EBIT over 5 years: stood at -$3.5 million in 2022, then surged by 609.61% to $18.0 million in 2023, then slumped by 141.61% to -$7.5 million in 2024, then surged by 848.94% to $56.0 million in 2025, then sank by 83.91% to $9.0 million in 2026.
- Business Quant data shows CGEN's EBIT at $9.0 million in Q1 2026, $56.0 million in Q4 2025, and -$7.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | Compugen | 215.59 Mn | 123.84 Mn | 352,000.00 | 9.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.02 Mn |
| Dec 31, 2025 | 56.04 Mn |
| Sep 30, 2025 | -7.89 Mn |
| Jun 30, 2025 | -25.22 Mn |
| Mar 31, 2025 | 8.40 Mn |
| Dec 31, 2024 | -7.48 Mn |
| Sep 30, 2024 | 4.50 Mn |
| Jun 30, 2024 | -20.40 Mn |
| Mar 31, 2024 | 8.49 Mn |
| Dec 31, 2023 | 17.98 Mn |
| Sep 30, 2023 | -10.63 Mn |
| Jun 30, 2023 | -30.48 Mn |
| Mar 31, 2023 | 10.13 Mn |
| Dec 31, 2022 | -3.53 Mn |
| Sep 30, 2022 | -12.21 Mn |
| Jun 30, 2022 | 28.56 Mn |
| Mar 31, 2022 | -9.71 Mn |
| Dec 31, 2021 | -8.78 Mn |
| Sep 30, 2021 | -6.33 Mn |
| Jun 30, 2021 | -9.50 Mn |